Supplementary Table S3 from CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table S3 lists the baseline demographics, clinical and prior treatment characteristics of the prospective RMC cohort used in the study.
Authors: Sandra L. Grimm, Menuka Karki, Kyle A. Blum, Jean-Philippe Bertocchio, Rong He, Durga N. Tripathi, Niki M. Zacharias, Justin M. Lebenthal, Rahul A. Sheth, Priya Rao, Giannicola Genovese, Zhen Lu, Robert C. Bast, Davis R. Ingram, Rossana Lazcano, Khalida M. Wani, Wei-Lien Wang, Alexander J. Lazar, Nizar M. Tannir, Cheryl L. Walker, Cristian Coarfa, Pavlos Msaouel
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4408535658